AR002845A1 - A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY, DNA SEQUENCE THAT CODES IT, RECOMBINANT VECTOR, CELLULA GUEST, PROCESS TO PREPARE DICHAENZYME, METHOD TO IMPROVE PROPERTIES, COMPOSITIONS THAT CONTAIN IT, DETERGENT COMPOSITION AND USE. - Google Patents

A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY, DNA SEQUENCE THAT CODES IT, RECOMBINANT VECTOR, CELLULA GUEST, PROCESS TO PREPARE DICHAENZYME, METHOD TO IMPROVE PROPERTIES, COMPOSITIONS THAT CONTAIN IT, DETERGENT COMPOSITION AND USE.

Info

Publication number
AR002845A1
AR002845A1 ARP960103594A AR10359496A AR002845A1 AR 002845 A1 AR002845 A1 AR 002845A1 AR P960103594 A ARP960103594 A AR P960103594A AR 10359496 A AR10359496 A AR 10359496A AR 002845 A1 AR002845 A1 AR 002845A1
Authority
AR
Argentina
Prior art keywords
compositions
dna sequence
detergent composition
recombinant vector
dichaenzyme
Prior art date
Application number
ARP960103594A
Other languages
Spanish (es)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of AR002845A1 publication Critical patent/AR002845A1/en

Links

Abstract

Una enzima modificada con una actividad lipolítica que comparada con la enzima emparentada tiene un agregado péptido en su terminal C o N o que tieneun agregado péptido en su terminal C y N. Además, se describe una secuencia de ADN que codificala enzima, un vector recombinante, una célula huésped, unproceso para preparar dicha enzima, un método para mejorar propiedades de la enzima, composicines que las contienen, composición detergente y uso de lascomposiciones.A modified enzyme with lipolytic activity that, compared to the related enzyme, has a peptide aggregate at its C or N terminus or that has a peptide aggregate at its C and N terminus. In addition, a DNA sequence encoding the enzyme, a recombinant vector, is described. , a host cell, a process for preparing said enzyme, a method for improving enzyme properties, compositions containing them, detergent composition and use of the compositions.

ARP960103594A 1995-07-14 1996-07-15 A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY, DNA SEQUENCE THAT CODES IT, RECOMBINANT VECTOR, CELLULA GUEST, PROCESS TO PREPARE DICHAENZYME, METHOD TO IMPROVE PROPERTIES, COMPOSITIONS THAT CONTAIN IT, DETERGENT COMPOSITION AND USE. AR002845A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK83295 1995-07-14
DK101395 1995-09-13
DK109695 1995-09-29
DK130695 1995-11-21
DK37296 1996-04-01

Publications (1)

Publication Number Publication Date
AR002845A1 true AR002845A1 (en) 1998-04-29

Family

ID=36997524

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103594A AR002845A1 (en) 1995-07-14 1996-07-15 A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY, DNA SEQUENCE THAT CODES IT, RECOMBINANT VECTOR, CELLULA GUEST, PROCESS TO PREPARE DICHAENZYME, METHOD TO IMPROVE PROPERTIES, COMPOSITIONS THAT CONTAIN IT, DETERGENT COMPOSITION AND USE.

Country Status (1)

Country Link
AR (1) AR002845A1 (en)

Similar Documents

Publication Publication Date Title
ATE500323T1 (en) SUBTILISIN VARIANT
FI962444A (en) New cellulase enzymes and systems for their expression
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
DE69633825D1 (en) MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY
DK0758383T3 (en) Soluble polypeptide fractions of the LAG-3 protein; method of manufacture; therapeutic composition; anti-idiotypic antibody
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
BR0009393A (en) Polypeptide, isolated nucleic acid sequence, nucleic acid construct, recombinant expression vector, recombinant host cell, method for producing polypeptide, use of polypeptide, and detergent composition
KR970707153A (en) Cathepsin 02 Protease (CATHEPSIN 02 PROTEASE)
ATE404583T1 (en) FUNCTIONAL ANTAGONISTS OF HEDGEHOG ACTIVITY
AR248044A1 (en) Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5.
DE69930955D1 (en) POLYPEPTIDES WITH LYSOPHOSPHOLIPASE ACTIVITY AND NUCLEIC ACIDS YOU CODE
DE69840230D1 (en) POLYPEPTIDES WITH PROLYLDIPEPTIDYLAMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS THAT CODE FOR IT
DE59509642D1 (en) METHOD FOR MODIFYING THE STABILITY OF ANTIBODIES
DE69535696D1 (en) Tripeptidyl aminopeptidase
MXPA00002111A (en) Biomolecules comprising an elastomeric peptide.
DE3786317D1 (en) PROTEIN ANALOGS OF THE TISSUE PLASMINOGEN ACTIVATOR.
DE59712235D1 (en) IMMUNOLOGICALLY ACTIVE PROTEINS OF BORRELIA BURGDORFERI, CODING NUCLEIC ACIDS, AND THEIR USE IN TEST KITS AND AS VACCINES
ATE464320T1 (en) NTB-A, A SURFACE MOLECULE IMPLIED IN THE ACTIVITY OF NATURAL KILLER CELLS (NK)
AU7843101A (en) Furin polypeptides with improved characteristics
SE8502540L (en) STABLE DENTALS CONTAINING DEXTRANAS
AR002845A1 (en) A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY, DNA SEQUENCE THAT CODES IT, RECOMBINANT VECTOR, CELLULA GUEST, PROCESS TO PREPARE DICHAENZYME, METHOD TO IMPROVE PROPERTIES, COMPOSITIONS THAT CONTAIN IT, DETERGENT COMPOSITION AND USE.
SE9602822D0 (en) New receptor
DE69634757D1 (en) VECTOR FOR THE EXPRESSION OF N-TERMINAL EXTENDED PROTEINS IN HEF-CELLS
BR9507473A (en) DNA sequence isolated vector host cell process to produce a homogeneous gp350 protein homogeneous gp350 protein pharmaceutical composition and use in homogeneous gp350 protein
DK0939769T3 (en) The vertebrate Smoothened proteins